AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis.
D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D003657:Decision Making; D015914:Estrogen Replacement Therapy; D005260:Female; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control* / Q000628:therapy; D026741:Physical Therapy Modalities; D018570:Risk Assessment; D014807:Vitamin D / Q000627:therapeutic use
D014807:Vitamin D; D002116:Calcitonin; D002118:Calcium; D019386:Alendronate